Navigation Links
Occlutech Obtains Favourable Court Ruling in Patent Litigation in The Hague Against AGA Medical
Date:10/30/2008

JENA, Germany, October 30 /PRNewswire/ -- Occlutech GmbH, the leading European manufacturer of cardiac occlusion devices, today announced that it has won its litigation case in The Hague, Holland, against AGA Medical Inc. regarding non-infringement of the Dutch version of the European patent; EP 0808138.

The patent court in The Hague stated that the disputed Occlutech products do not infringe the Dutch part of; EP 0808138 (equivalent of German patent DE 695 34 505.2) held by AGA Medical. In reaching its decision, the Dutch court had full access to the now appealed 2007 German District Court's ruling resulting from litigation initiated by AGA Medical in 2006.

Patent infringement litigation against a previous version of the occluder was originally filed in Germany by AGA Medical Inc. In Occlutech's view, AGA Medical argued for an extraordinarily broad interpretation of its granted patent claims, contributing to Occlutech's defeat in the first instance district court's ruling. The broad scope of the claim, interpreted before the German court in 2007, was however not accepted by the European Patent Office's examiners during the original patent granting procedure. This and several other factors created significant and in Occlutech's view justified reasons for appealing the district court ruling in Germany and for Occlutech to initiate non-infringement proceedings internationally and, in particular, before the patent court in The Hague, Holland. The Dutch patent court's ruling will become final if no appeal is filed.

In a statement, Tor Peters, Chairman of Occlutech AB, says: "We are very pleased with the decision of the patent court in The Hague, which had access to all relevant information available, including information submitted at the appeal proceedings in Germany. This shows that Occlutech's patented technology is substantially different from AGA's and we look forward to continue our surge, establishing a global presence."

Occlusion devices are used to treat structural heart disease, including structural heart defects and abnormalities such as Atrial Septal Defects, (ASD), and Patent Foramen Ovale (PFO, an undesired channel between the heart's two atria, present in up to 25% of the population), in minimally invasive, non-surgical procedures. The market for PFO occluders is expected to expand significantly as the link between PFO and stroke, that is the third most common cause of death, as well as severe migraine becomes increasingly well documented.

Contacts:

Tor Peters

tor.peters@occlutech.se

+46-42-33-65-20

Susanne Goransson

susanne.goransson@occlutech.net

+46-42-33-65-21


'/>"/>
SOURCE Occlutech GmbH
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. AGA Medical Corporation Responds to Occlutech Statement on the Status of the Ongoing Patent Litigation in Europe
2. Occlutech Clarifies Statement Regarding Favourable Opinion Obtained From AIPPI With Regard to Patents Held by AGA Medical
3. Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimers Vaccine in 19 Countries
4. Botaneco obtains $2.4 million in funding from AVAC
5. Ganeden Biotech Obtains Self-Affirmed GRAS Status for Probiotic Ingredient, GanedenBC30 (Bacillus coagulans GBI-30, 6086)
6. Neptune Technologies & Bioressources Inc. obtains Complementary Medicine approval in Australia for NKO(R)
7. NEXCORE Technology Obtains Licenses for Revolutionary Fluid Management System
8. China Kangtai Cactus Biotech, Inc. Obtains $500,000 Equity Financing
9. PerOs obtains USDA Establishment and Product Licenses for its oral vaccine formulations
10. Biofisica Obtains $2.3 Million in Financing From Investors
11. First Taxane-Based Non-Anthracycline Containing Chemotherapy in Combination With Herceptin (TCH) for HER2 Positive Early Breast Cancer Patients Obtains Approval From the FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... 09, 2016 , ... There’s a winning streak at Voxx Analytics: the tech ... after winning the award last year as well. Employees nominate their companies for the ... Vesely pointed to the tech company’s upbeat environment as a reason. “We don’t answer ...
(Date:12/9/2016)... ... 09, 2016 , ... Aditya Humad, Acting CFO of AxioMed and Managing Partner ... United States, Axiomed is now gaining interest from Silicon Valley. “It was satisfying to ... went on to say that, “We expect interest to continue to rise as AxioMed ...
(Date:12/9/2016)... PHILADELPHIA , Dec. 9, 2016  A ... Temple University are moving one step closer to ... orthopedic applications. OrthoMend Research, Inc., a start-up company ... acquired the exclusive license for these novel absorbable ... to develop them for commercial use. The company ...
(Date:12/9/2016)... - Portage Biotech Inc. ("Portage" or "the Company") (OTC: ... that Biohaven has issued today the following press release: ... (PRWEB) Dec 9, 2016 - Biohaven Pharmaceutical Holding Company ... U.S. Food and Drug Administration ("FDA") has granted the ... BHV-0223, an orally dissolving tablet being developed for the ...
Breaking Biology Technology:
(Date:12/6/2016)... , Dec. 6, 2016 Securus ... justice technology solutions for public safety, investigation, corrections ... jointly announced today a five (5) year funding ... agreement to expand the rehabilitation and reentry support ... PEP History Established in 2004, the Prison Entrepreneurship ...
(Date:11/30/2016)... , Nov. 30, 2016 Not many of us realize that we spend ... recovery so we need to do it well. Inadequate sleep levels have been found ... pressure, stroke, diabetes, and even cancer. Maybe now is the best time ... could help them to manage their sleep quality? Continue ... ...
(Date:11/29/2016)... Nearly one billion matches per second with DERMALOG,s ... ... DERMALOG is Germany's largest Multi-Biometric ... Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric supplier: The company's Fingerprint Identification System is ...
Breaking Biology News(10 mins):